The Sanford Guide to Antimicrobial Therapy 2023

Coverage includes:

• Clinical syndromes
  • pathogens
  • bacterial
  • fungal
  • mycobacterial
  • parasitic
  • viral
• Anti-infective agents
  • dosing
    • pediatric adjustments
    • renal adjustments
  • adverse effects
  • activity
  • pharmacology
  • interactions
• Preventative therapy

What's new in 2023:
Numerous changes throughout, with major changes in the following areas:

• Treatment recommendations have been updated based on recent references and guidelines. 
• Newly-approved drugs are included in various tables throughout the edition.
• Table 1: treatment updates include otitis media, traveler’s diarrhea, duodenal ulcer, gonorrhea, PID, cystitis, bronchiectasis, gram negative infections (also Table 5), pharyngitis, human bites, rheumatic fever and Lemierre’s syndrome.
• Table 3: revised based on new references citing clinical trials for “shorter is better” duration of therapy.
• Table 9A:  pharmacology data has been completely reworked for better consistency and clarity.
• Table 14: ART regimens for HIV have been revised to reflect newer drugs and updated guidelines. The same has been done for HCV treatment regimens.